Argeris N. Karabelas, Director at Vanda Pharmaceuticals Inc. (VNDA), sold 437,000 shares at $26.74 ($11.8M) on 2007-02-21, disclosed to the SEC on 2007-02-22.
Open-market sale of $11.8M VNDA by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.37 | 12,840 | $351K | 3.0% |
| 2 | $27.37 | 187,160 | $5.1M | 43.4% |
| 3 | $26.74 | 15,215 | $407K | 3.4% |
| 4 | $26.74 | 221,785 | $5.9M | 50.2% |
| Total | $27.03 avg | 437,000 | $11.8M | 100% |
| Filing → |
| RGNX | SELL | 2024-08-05 | $136K | — | Filing → |
| RGNX | SELL | 2024-07-30 | $166K | — | Filing → |
| RGNX | SELL | 2024-07-03 | $113K | — | Filing → |